close

Enter

Log in using OpenID

Contract Pharmaceutical Manufacturing Market To See Incredible Growth By 2026

embed
Pharmaceutical companies are now pushing hard to reduce overall manufacturing and research costs by outsourcing various processes related to research, development and manufacturing
Contract Pharmaceutical Manufacturing Market To
See Incredible Growth By 2026
Contract Pharmaceutical Manufacturing Market, by Service Type (Contract
Manufacturing Organization (CMO) (API Manufacturing, Final Dosage Form
Manufacturing and Packaging), Contract Research Organization (CRO) (Drug
Discovery, Preclinical Studies, Early Phase I – IIa, Phase IIa – III, Phase IIIb – IV,
Medical Coding and Writing, Monitoring, Clinical Data Management, Biostatistics, Site Management and Protocol Development), by Molecule Type
(Small Molecules and Large Molecules), and by Region (North America, Latin
America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook,
and Opportunity Analysis, 2018-2026
Pharmaceutical companies are now pushing hard to reduce overall manufacturing and research costs by
outsourcing various processes related to research, development and manufacturing. Furthermore, patent
expiration and generic drug competition, continue to fuel demand for pharmaceutical contract
manufacturing organizations in the market.
Rising number of Food and Drug Administration (FDA) approvals and clinical trials are supporting
growth of biopharmaceutical industry, which in turn is fueling growth of the Contract Pharmaceutical
Manufacturing Market. For instance, according to ClinicalTrials.gov, from September 2008 to
October 2018, there were around 288,064 clinical trial studies registered. In addition, there is a
significant increase over the past few years with registered clinical studies of 205,428, 233,234, and
262,429 in 2015, 2016, and 2017, respectively.
Furthermore, stringent regulatory policies for clinical research studies and manufacturing make entire
drug manufacturing process more complex, as it requires more resources to develop new drugs and
biologics. These processes require expertise in broad scientific disciplines of preclinical, clinical,
ancillary clinical in chemistry, packaging, manufacturing, project management, and regulatory affairs,
which are provided by the CROs and CMOs. This is considered as a major reason for pharmaceutical
companies to outsource clinical trials and manufacturing processes.
Market Dynamics
Contract manufacturing organizations (CMOs) provide wide range of manufacturing services, which
include contract packaging, quality testing, and development service to pharmaceutical and
biotechnology industries. Biopharmaceutical companies prefer CMOs due to the complexity involved
in manufacturing process of biomolecules, as it consists of different shape, size, and behavior with
significantly complex process than pharmaceutical drugs. Furthermore, by outsourcing manufacturing
capabilities from contract manufacturing organization, allows recruiter firms to focus more on the
research and development (R&D), product development, and marketing aspects.
Pharmaceutical market is increasingly concentered with generic products and is highly competitive
with various companies located in Asia Pacific, which are entering into the developed markets such as
the U.S., Germany, France, and the U.K. Rising number of patents expiring in the near future serves to
be a major opportunity for generic drugs manufacturers to prosper in the market.
Ask For Sample Copy Of This Business Research Report :
https://www.coherentmarketinsights.com/insight/request-sample/2397
Furthermore, mergers and acquisitions between generic drug manufacturers, with major players
focusing on enhancing their product portfolio through inorganic strategies, will support the addition of
generic drug portfolio into company’s offering and thus, generating demand for CMOs to fulfil it.
For instance, in August 2016, Teva Pharmaceuticals Industries strengthened its position in the generic
drugs market through acquisition of the generic segment of Allergan, plc for US$ 40.5 billion. This
resulted in significant growth in revenue contribution of its generic drug segment, pegged at US$ 9.5
billion in 2016.
Detailed Segmentation:
•Global contract pharmaceutical manufacturing market, By Service Type:
•Contract Manufacturing Organization (CMO)
•API Manufacturing
•Final dosage form manufacturing
•Packaging
•Contract Research Organization (CRO)
•Drug Discovery
•Preclinical studies
•Early Phase I - IIa
•Phase IIa - III
•Phase IIIb - IV
•Medical coding and writing
•Monitoring
•Clinical Data Management
•Bio-statistics
•Site management
•Protocol development
•Global Contract Pharmaceutical Manufacturing Market, By Molecule Type:
•Small Molecules
•Large Molecules
Rising Demand for Generic Drugs is expected to Propel the Market Growth
Development of generic drugs offer opportunities for manufacturers, as consumers’ demand for costeffective pharmaceuticals is increasing. Patients being treated for chronic disease using generic drug
are more likely to continue their drug therapy and have their prescriptions refilled than those using
branded drugs. Moreover, the expiration of patents, emerging markets, increasing geriatric population,
rising prevalence of chronic diseases, and the efforts of governments and healthcare service providers
have contributed to the increased use and acceptance of generic drugs. This increasing demand for
generic drugs is offering lucrative growth opportunity for contract pharmaceutical manufacturing
organizations in the near future.
Competitive Analysis
Some of the key players operating in the contract pharmaceutical manufacturing market are Accenture
plc, Cognizant Technology Solutions, ATOS SE, Catalent, Inc., Covance, Inc., Boehringer Ingelheim
GmbH, Genpact Limited, Lonza Group, PAREXEL International Corporation, Quintiles Transnational
Corporation, Abbvie, Inc., Baxter International Inc., Dr. Reddy’s Laboratories Ltd., Aurobindo Pharma,
Pfizer, Inc., The Almac Group, Teva Pharmaceutical Industries Ltd. and Piramal Enterprises Ltd.
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready
syndicated research reports, custom market analysis, consulting services, and competitive analysis
through various recommendations related to emerging market trends, technologies, and potential
absolute dollar opportunity.
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1–206–701–6702
Email: [email protected]
Author
ravikiran
ravikiran254   documents Email
Document
Category
Health and Medicine
Views
8
File Size
395 KB
Tags
manufacturing
1/--pages
Report inappropriate content